SimPath

SimPath SimPath is an organization dedicated to innovation in the synthetic biology industry. SimPath is the “one-stop” resource for proper DNA assembly.

SimPath combines state-of-the-art DNA synthesis and assembly methods to construct multiple arrangements of a DNA assembly quicker and cheaper than present day services. Our advantage is our assembly method which is 100% flexible in how DNA parts can be rearranged, allowing us to synthesize a DNA part only once for its use in any arrangement of an assembly. In addition, SimPath provides a user-frie

ndly, intuitive web-interface for designing assemblies. When synthetic biologists want to design and build assemblies from multiple DNA parts, they no longer have to choose which step to sacrifice: DNA design, synthesis, or assembly.

SimPath's core technology, TNT Cloning, was recently named one of the top R&D technologies of 2018."Together, the R&D 10...
08/22/2018

SimPath's core technology, TNT Cloning, was recently named one of the top R&D technologies of 2018.

"Together, the R&D 100 Awards presentation event and the R&D 100 Conference explore the most significant strides in R&D that you will not find elsewhere—offering an enriching, one-of-a-kind experience for R&D professionals of all levels and specialties."

R&D Magazine’s 2017 Scientist of the Year is Cori Bargmann, PhD, the president of science at the Chan Zuckerberg Initiative.

One of our co-founders, Jeremy Baldi, was recently interviewed by FundingSage. Check out the article here!
12/28/2017

One of our co-founders, Jeremy Baldi, was recently interviewed by FundingSage. Check out the article here!

SimPath’s core technology, TNT-cloning, offers the first truly scalable DNA assembly resource. It's faster & more cost-effective than alternative solutions.

10/26/2017

One of our co-founders was recently interviewed!

Knoxville area readers may recall Rob Moseley and a company named SimPath that presented at the 2015 “Start-up Day” celebration.

We're happy to announce we've secured an exclusive license for our core technology!
10/19/2017

We're happy to announce we've secured an exclusive license for our core technology!

OAK RIDGE, Tenn., Oct. 16, 2017--SimPath has licensed a novel cloning system developed by the Department of Energy's Oak Ridge National Laboratory that generates and assembles the biological building blocks necessary to synthetically bioengineer new medicines and fuels.Knoxville, Tennessee-based sta...

05/19/2017
05/18/2017

We've been selected to pitch at 36 I 86! Thanks LaunchTN! We are excited for this opportunity and to make new connections!

Address

Knoxville, TN
37919

Website

Alerts

Be the first to know and let us send you an email when SimPath posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category